RxSight, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 50 rows, 50 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-08-03: Reporting owner RxSight I, LLC; Form 4; Security Series H Preferred Stock; Transaction C Conversion of derivative security.
- 2021-08-03: Reporting owner Wolfen Richard M.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2021-08-03: Reporting owner Wolfen Richard M.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2021-08-03: Reporting owner Wolfen Richard M.; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
RXST insiders transactions against the stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-08-03 | RxSight I, LLC 10% Owner | 4 | Series H Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,016,778 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series A Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −2,800 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −11,714 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series B Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −2,017 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −246,054 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series C Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −398,810 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series D Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −10,807 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series D Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −43,547 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series E Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −4,840 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series E Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −18,150 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series F Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −154,886 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series G Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −42,552 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series G Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −357,227 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series H Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −9,680 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series H Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −157,709 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series H Preferred Stock Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +1,452 1,452 owned after | $12.40 exercise price | $16.35 | 2021-08-05 |
| 2021-08-03 | Wolfen Richard M. Director | 4 | Series H Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −1,452 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Schwartz Daniel Mark Director | 4 | Series C Preferred Stock Derivative · Direct | C Conversion of derivative security | −3,872 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Robertson Bruce C Director | 4 | Series G Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −968,054 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Robertson Bruce C Director | 4 | Series H Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −403,355 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Robertson Bruce C Director | 4 | Series H Preferred Stock Derivative · Indirect · See footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +60,503 60,503 owned after | $12.40 exercise price | $16.35 | 2021-08-05 |
| 2021-08-03 | Robertson Bruce C Director | 4 | Series H Preferred Stock Derivative · Indirect · See footnote | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | −46,875 13,628 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Robertson Bruce C Director | 4 | Series H Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −13,628 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Tammenoms Bakker Juliet Director | 4 | Series G Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −1,613,423 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Tammenoms Bakker Juliet Director | 4 | Series H Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −242,013 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Tammenoms Bakker Juliet Director | 4 | Series H Preferred Stock Derivative · Indirect · See footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +36,302 36,302 owned after | $12.40 exercise price | $16.35 | 2021-08-05 |
| 2021-08-03 | Tammenoms Bakker Juliet Director | 4 | Series H Preferred Stock Derivative · Indirect · See footnote | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | −28,125 8,177 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | Tammenoms Bakker Juliet Director | 4 | Series H Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −8,177 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-08-03 | LINK WILLIAM J PHD Director, 10% Owner | 4 | Series H Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −2,016,778 0 owned after | $0.00 | $16.35 | 2021-08-05 |
| 2021-07-29 holding as of filing | RxSight I, LLC 10% Owner | 3 | Series H Preferred Stock Derivative · Direct | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Schwartz Daniel Mark Director | 3 | Series C Preferred Stock Derivative · Direct | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Robertson Bruce C Director | 3 | Series G Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Robertson Bruce C Director | 3 | Series H Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series A Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series B Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series B Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series C Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series D Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series D Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series E Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series E Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series F Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series G Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series G Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series H Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Series H Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Tammenoms Bakker Juliet Director | 3 | Series G Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Tammenoms Bakker Juliet Director | 3 | Series H Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2021-07-29 | ||
| 2021-07-29 holding as of filing | LINK WILLIAM J PHD Director, 10% Owner | 3 | Series H Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |